Additionally, Babeker’s team’s investigation into the fully human monoclonal antibody M16Ab in ovarian cancer immune PET imaging revealed that the 89Zr-DFO-M16Ab conjugate specifically targets MUC16-positive tumor cells, underscoring the potential of fully human antibodies in diagnostic imaging and radiopharmaceutical development (148). The gene discussed is MUC16; the disease is ovarian carcinoma.